Brown, Lisle/Cummings, Inc. Abbott Laboratories Transaction History
Brown, Lisle/Cummings, Inc.
- $376 Billion
- Q2 2025
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 4,201 shares of ABT stock, worth $540,038. This represents 0.15% of its overall portfolio holdings.
Number of Shares
4,201
Previous 4,144
1.38%
Holding current value
$540,038
Previous $550 Million
3.94%
% of portfolio
0.15%
Previous 0.16%
Shares
10 transactions
Others Institutions Holding ABT
# of Institutions
3,575Shares Held
1.38BCall Options Held
9.72MPut Options Held
8.83M-
Vanguard Group Inc Valley Forge, PA170MShares$21.8 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$9.98 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.59 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.52 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $225B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...